Proteinkinase Inhibitors - Couverture souple

 
9783030681821: Proteinkinase Inhibitors

Synopsis

Overview chapters introduce the newcomer to the topic covered

Series covers hot topics of frontier research summarized by reputed scientists in the field

Volumes are useful and of relevance for a long period of time

Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.

À propos de l?auteur

Stefan Laufer is a Professor of Pharmaceutical/Medicinal Chemistry at Tuebingen University, Germany, and he had previously worked for 10 years in the Pharmaceutical Industry. His research interests are anti-inflammatory and cancer drug discovery with various eicosanoid (COX-1,2,3, LOXs, mPGES1, cPLA2) and protein kinase targets (p38, JAKs, JNKs, CK1d, mtEGRFs). Three compounds from his lab entered clinical development phases. Dr. Laufer chairs the ICEPHA (Interfaculty Center for Pharmacogenomics and Drug Research) and TüCADD, Tuebingen Center for Academic Drug Discovery. As part of this work, a proprietary kinase inhibitor collection is established (TüKIC, 10.000 cpds). He authored more than 500 publications, 14 books/bookchapters, and is inventor in 42 patent families.

Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.

Autres éditions populaires du même titre

9783030681791: Proteinkinase Inhibitors

Edition présentée

ISBN 10 :  3030681793 ISBN 13 :  9783030681791
Editeur : Springer Nature Switzerland AG, 2021
Couverture rigide